Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haleon is a global leader in consumer health, formed in July 2022 through the demerger of GSK's consumer healthcare business. In Australia, the company operates a vast portfolio of trusted over-the-counter brands including Panadol, Voltaren, Sensodyne, and Advil. The company focuses on five key categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals and Supplements. Haleon combines deep human understanding with trusted science to deliver better everyday health. The Australian division includes significant commercial operations and manufacturing facilities, such as the site in Ermington, New South Wales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlaxoSmithKline Consumer Healthcare Australia.